Anal cancer screening: Barriers and facilitators among ethnically diverse gay, bisexual, transgender, and other men who have sex with men

Journal of Gay and Lesbian Social Services

Volumn 20, Issue 4, 2008, Pages 328-353

  Newman, Peter A ^a   Roberts, Kathleen J ^b   Masongsong, Emmanuel ^b   Wiley, D J ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anal cancer screening; Ethnic minorities; Gay men; HPV; MSM; Pap test; Qualitative methods

Indexed keywords

EID: 69849119340     PISSN: 10538720     EISSN: 15404056     Source Type: Journal    
DOI: 10.1080/10538720802310733     Document Type: Article

References (57)

1. American Cancer Society. (2003). Cancer facts & figures: 2003. Atlanta, GA: American Cancer Society.
2. Anal cancer on increase in gay men. (2000, April 5). The Advocate, online.
3. Anal cancer risks higher among gay men, HIV-positive men. (2001, April 3). The Advocate, online.
4. Berry, J. M., Palefsky, J. M., & Welton, M. L. (2004). Anal cancer and its precursors in HIV-positive patients: Perspectives and management. Surgical Oncology Clinics of North America, 13(2), 355-373.
5. Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., et al. (1995). Prevalence of human papillomavirus in cervical cancer: A worldwide perspective (International biological study on cervical cancer (IBSCC) study group). Journal of the National Cancer Institute, 87(11), 796-802.
6. Chamaz, K. (1997). A social worlds research adventure: The case of reproductive science. Thousand Oaks, CA: Sage.
7. Chin-Hong, P. V., & Palefsky, J. M. (2005). Human papillomavirus anogenital disease in HIV-infected individuals. Dermatologic Therapy, 18(1), 67-76.
8. Christopherson, W. M., & Scott, M. A. (1977). Trends in mortality from uterine cancer in relation to mass screening. Acta Cytologica, 21(1), 5-9.
9. Clinicians call for anal pap tests for gay men. (2003, February 20). The Advocate, online.
10. Daling, J. R., Weiss, N. S., Hislop, T. G., Maden, C., Coates, R. J., Sherman, K. J., et al. (1987). Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. New England Journal of Medicine, 317(16), 973-977.
11. Eltom, M. A., Jemal, A., Mbulaiteye, S. M., Devesa, S. S., & Biggar, R. J. (2002). Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. Journal of the National Cancer Institute, 94(16), 1204-1210.
12. Frisch, M., Biggar, R. J., & Goedert, J. J. (2000). Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. Journal of the National Cancer Institute, 92(18), 1500-1510.
13. Frisch, M., Fenger, C., van den Brule, A. J., Sorensen, P., Meijer, C. J., Walboomers, J. M., et al. (1999). Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Research, 59(3), 753-757.
14. Frisch, M., Glimelius, B., van den Brule, A. J., Wohlfahrt, J., Meijer, C. J., Walboomers, J. M., et al. (1997). Sexually transmitted infection as a cause of anal cancer. New England Journal of Medicine, 337(19), 1350-1358.
15. Gay and Lesbian Medical Association. (2001). The HP2010 companion document for LGBT health. San Francisco: Gay and Lesbian Medical Association.
16. Goffman, E. (1963). Stigma: Notes on the management of spoiled identity. Englewood Cliffs, NJ: Prentice-Hall.
17. Goldie, S. J., Kuntz, K. M., Weinstein, M. C., Freedberg, K. A., Welton, M. L., & Palefsky, J. M. (1999). The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. Journal of the American Medical Association, 281(19), 1822-1829.
18. Grulich, A. E., Li, Y., McDonald, A. M., Correll, P. K., Law, M. G., & Kaldor, J. M. (2001). Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. AIDS, 15(5), 629-633.
19. Kim, K., Rigal, R. D., Patrick, J. R., Walters, J. K., Bennett, A., Nordin, W., et al. (1978). The changing trends of uterine cancer and cytology: A study of morbidity and mortality trends over a twenty-year period. Cancer, 42(5), 2439-2449.
20. Kiviat, N. B., Critchlow, C. W., Hawes, S. E., Kuypers, J., Surawicz, C., Goldbaum, G., et al. (1998). Determinants of human immunodeficiency virus DNA and RNA shedding in the anal-rectal canal of homosexual men. Journal of Infectious Diseases, 177(3), 571-578.
21. Klencke, B. J., & Palefsky, J. M. (2003). Anal cancer: An HIV-associated cancer. Hematology/Oncology Clinics of North America, 17(3), 859-872.
22. Koutsky, L. A., Galloway, D. A., & Holmes, K. K. (1988). Epidemiology of genital human papillomavirus infection. Epidemiologic Reviews, 10, 122-163.
23. Lincoln, Y., & Guba, E. (1985). Naturalistic inquiry. Beverly Hills, CA: Sage.
24. Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recommendations and Reports, 56(RR-2), 1-24.
25. Melbye, M., Cote, T. R., Kessler, L., Gail, M., & Biggar, R. J. (1994). High incidence of anal cancer among AIDS patients: The AIDS/cancer working group. The Lancet, 343(8898),636-639.
26. Melbye, M., Rabkin, C., Frisch, M., & Biggar, R. J. (1994). Changing patterns of anal cancer incidence in the United States, 1940-1989. American Journal of Epidemiology, 139(8),772-780.
27. Melbye, M., & Sprogel, P. (1991). Aetiological parallel between anal cancer and cervical cancer. The Lancet, 338(8768), 657-659.
28. Morgan, D. (1998). Focus group. Thousand Oaks, CA: Sage.
29. Munoz, N. (2000). Human papillomavirus and cancer: The epidemiological evidence. Journal of Clinical Virology, 19(1-2), 1-5.
30. National Center for Health Statistics & Centers for Disease Control and Prevention. (1999). U.S. mortality public use data tapes 1960-1996, U.S. mortality volumes 1930-1959. Retrieved August 31, 2008, from http://www.cancer.org/statistics/cff2000/data/female=site.html
31. Nearly 40% of gay men infected with dangerous strain of HPV. (2002, March 9-11). The Advocate, online.
32. Ohaeri, J. U., Campbell, O. B., Ilesanmil, A. O., & Ohaeri, B. M. (1998). Psychosocial concerns of Nigerian women with breast and cervical cancer. Psychooncology, 7(6), 494-501.
33. Palefsky, J. M. (1998). Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. Journal of the National Cancer Institute Monographs, 23, 15-20.
34. Palefsky, J. M. (1999). Anal squamous intraepithelial lesions: Relation to HIV and human papillomavirus infection. Journal of Acquired Immune Deficiency Syndromes, 21(Suppl. 1), S42-S48.
35. Palefsky, J. M. (2000). Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Seminars in Oncology, 27(4), 471-479.
36. Palefsky, J. M., & Holly, E. A. (2003). Immunosuppression and co-infection with HIV. Journal of the National Cancer Institute Monographs, 2003(31), 41-46.
37. Palefsky, J. M., Holly, E. A., Efirdc, J. T., Da Costa, M., Jay, N., Berry, J. M., et al. (2005). Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIVpositive men who have sex with men. AIDS, 19(13), 1407-1414.
38. Palefsky, J. M., Holly, E. A., Ralston, M. L., Arthur, S. P., Jay, N., Berry, J. M., et al. (1998). Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: Prevalence and risk factors. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 17(4), 320-326.
39. Palefsky, J. M., Holly, E. A., Ralston, M. L., Da Costa, M., Bonner, H., Jay, N., et al. (2001). Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. Journal of Acquired Immune Deficiency Syndromes, 28(5), 422-428.
40. Palefsky, J. M., Holly, E. A., Ralston, M. L., Da Costa, M., & Greenblatt, R. M. (2001). Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. Journal of Infectious Diseases, 183(3), 383-391.
41. Palefsky, J. M., Holly, E. A., Ralston, M. L., Jay, N., Berry, J. M., & Darragh, T. M. (1998). High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS, 12(5), 495-503.
42. Palefsky, J., Holly, E., Ralston, M., Jay, N., Berry, J., & Darragh, T. (July 7-12, 2002). Effect of HAART on incidence of anal intraepithelial neoplasia grade 3 among hiv-positive men who have sex with men. Paper presented at the XIV International AIDS Conference, Barcelona, Spain.
43. Papanicolaou, G. (1928). New cancer diagnosis. Paper presented at the Third Race Betterment Conference, Battle Creek, MI.
44. Papanicolaou, G. N. (1954). Cytological evaluation of smears prepared by the tampon method for the detection of carcinoma of the uterine cervix. Cancer, 7(6), 1185-1190.
45. Penington, E. C., & Hutson, J. M. (2002). The cloacal plate: The missing link in anorectal and urogenital development. British Journal of Urology International, 89(7), 726-732.
46. Piketty, C., Darragh, T. M., Heard, I., Da Costa, M., Bruneval, P., Kazatchkine, M. D., et al. (2004). High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sexually Transmitted Diseases, 31(2),96-99.
47. Rabkin, C. S. (2001). AIDS and cancer in the era of highly active antiretroviral therapy (HAART). European Journal of Cancer, 37(10), 1316-1319.
48. Rothman, K. J., & Greenland, S. (1998). Precision and validity in epidemiologic studies. In K. J. Rothman & S. Greenland (Eds.), Modern epidemiology 2nd ed. (pp. 115-134). Philadelphia: Lippencott Raven.
49. Scholefield, J. H., Sonnex, C., Talbot, I. C., Palmer, J. G., Whatrup, C., Mindel, A., et al. (1989). Anal and cervical intraepithelial neoplasia: Possible parallel. The Lancet, 2(8666),765-769.
50. Simple screening test could detect cancer lesions in gay men. (2000, June 1). Harvard Gazette.
51. Sobhani, I., Vuagnat, A., Walker, F., Vissuzaine, C., Mirin, B., Hervatin, F., et al. (2001). Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirusinfected individuals. Gastroenterology, 120(4), 857-866.
52. Tuller, D. (2007, January 30). New vaccine for cervical cancer could prove useful in men, too. The New York Times.
53. U.S. Food and Drug Administration. (2006). Product approval information-licensing action: Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, Gardasil (Edited by U.S. Public Health Service). Washington, DC: Department of Health and Human Services.
54. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189(1), 12-19.
55. We the People of Delaware Valley. (1999, August). Anal cancer tests recommended for gay men with HIV. Being Alive.
56. Wiley, D. J., Huh, J., Rao, J. Y., Chang, C., Goetz, M., Poulter, M., et al. (2005). Methylation of human papillomavirus genomes in cells of anal epithelia of HIV-infected men. Journal of Acquired Immune Deficiency Syndromes, 39(2), 143-151.
57. zur Hausen, H. (2000). Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. Journal of the National Cancer Institute, 92(9), 690-698.